I am a
Home I AM A Search Login

Papers of the Week

Papers: 24 Aug 2019 - 30 Aug 2019

Pharmacology/Drug Development

2019 Aug 22

Medicines (Basel)



Pathological Mechanisms and Therapeutic Targets for Trigeminal Neuropathic Pain.


Bista P, Imlach WL
Medicines (Basel). 2019 Aug 22; 6(3).
PMID: 31443547.


Trigeminal neuropathic pain is a chronic pain condition caused by damage or inflammation of the trigeminal nerve or its branches, with both peripheral and central nervous system dysfunction contributing to the disorder. Trigeminal pain conditions present with diagnostic and therapeutic challenges to healthcare providers and often require multiple therapeutic approaches for pain reduction. This review will provide the overview of pathophysiology in peripheral and central nociceptive circuits that are involved in neuropathic pain conditions involving the trigeminal nerve and the current therapeutics that are used to treat these disorders. Recent advances in treatment of trigeminal pain, including novel therapeutics that target ion channels and receptors, gene therapy and monoclonal antibodies that have shown great promise in preclinical studies and clinical trials will also be described.